Abstract: A follow focus controller and a follow focus system are provided. The follow focus controller includes: a body; a first follow focus adjusting assembly and a second follow focus adjusting assembly, arranged on the body; and a control assembly, arranged on the body and configured to generate a first follow focus control signal according to a rotation of the first follow focus adjusting assembly or to generate a second follow focus control signal according to a rotation of the second follow focus adjusting assembly. The first follow focus control signal and the second follow focus control signal are configured to control different follow focus motors.

Abstract: It is suitable for the field of computer graphic processing technologies, and provides a method and apparatus for repairing a graphics processing unit (GPU) video memory access based on active error detection. A small video memory is first distributed and used for error detection of video memory access, and a problem of video memory data access abnormality is found in time through a regular active detection. When the video memory data access abnormality is found, a GPU desktop driving module can suspend a display picture update operation, and a GPU kernel driving module first suspends all video memory access, then re-initializes a video memory controller and repairs the video memory access abnormality, and then restores an access of all the modules to a video memory to normal, refreshes a desktop, and restores a graphic desktop to a normal state.

Abstract: It is suitable for the field of computer graphic processing technologies, and provides a method and apparatus for repairing a graphics processing unit (GPU) video memory access based on active error detection. A small video memory is first distributed and used for error detection of video memory access, and a problem of video memory data access abnormality is found in time through a regular active detection. When the video memory data access abnormality is found, a GPU desktop driving module can suspend a display picture update operation, and a GPU kernel driving module first suspends all video memory access, then re-initializes a video memory controller and repairs the video memory access abnormality, and then restores an access of all the modules to a video memory to normal, refreshes a desktop, and restores a graphic desktop to a normal state.

Abstract: This invention relates to certain pyrimidine derivative inhibitors of JAK-2, having Formula (I): wherein D, E, L, Z, R1, R2, R25, and n1 are as defined in the specification, pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods of use thereof.

Abstract: A compound having Formula I: or a pharmaceutically acceptable salt thereof, wherein X, R, R and R are as defined in the specification; pharmaceutical compositions thereof; and methods of use thereof. The compounds of Formula I are inhibitors of Casein kinase II (CK2) pathways.

Abstract: A compound having Formula I or II (Formula I) or (Formula II), or a pharmaceutically acceptable salt thereof, wherein X, Z, R1, R2, R11 and R12 are as defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.

Abstract: A compound having Formula (I) or a pharmaceutically acceptable salt thereof, wherein X, R1 and R2 are defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.

Abstract: This invention relates to the field of protein tyrosine kinases and inhibitors thereof. In particular, the invention relates to inhibitors of JAK-2, pharmaceutical compositions of the compounds for inhibiting JAK-2, methods of inhibiting JAK-2 in a cell, comprising contacting a cell in which inhibition of JAK-2 is desired with a compound or pharmaceutical composition comprising a compound according to the invention. The also comprises methods of treating a disease or condition that involves JAK-2 comprising administering to a patient a pharmaceutical composition comprising a compound according to the invention.

Abstract: A compound having Formula I: or a pharmaceutically acceptable salt thereof, wherein X, R, R and R are as defined in the specification; pharmaceutical compositions thereof; and methods of use thereof. The compounds of Formula I are inhibitors of Casein kinase II (CK2) pathways.

Abstract: A compound having Formula I or II (Formula I) or (Formula II), or a pharmaceutically acceptable salt thereof, wherein X, Z, R1, R2, R11 and R12 are as defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.

Abstract: This invention relates to the field of protein tyrosine kinases and inhibitors thereof. In particular, the invention relates to inhibitors of JAK-2, pharmaceutical compositions of the compounds for inhibiting JAK-2, methods of inhibiting JAK-2 in a cell, comprising contacting a cell in which inhibition of JAK-2 is desired with a compound or pharmaceutical composition comprising a compound according to the invention. The also comprises methods of treating a disease or condition that involves JAK-2 comprising administering to a patient a pharmaceutical composition comprising a compound according to the invention.

Abstract: This invention relates to certain pyrimidine derivative inhibitors of JAK-2, having Formula (I): wherein D, E, L, Z, R1, R2, R25, and n1 are as defined in the specification, pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods of use thereof.

Abstract: A compound having Formula (I) or a pharmaceutically acceptable salt thereof, wherein X, R1 and R2 are defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.